Tag Archives: INTA
INCUINTA and Bioinnovo apply their knowledge to fight COVID19
Argentine researchers used two different platforms to neutralize the virus with “nanobodies” derived from llamas [...]
Nov
Bioinnovo will increase production of the vaccine against Bovine Viral Diarrhea Virus
Bioinnovo, a public-private partnership between INTA and Vetanco S.A., will allocate an important support, granted by the Ministry [...]
Nov
A new achievement in the fight against COVID-19
A multidisciplinary team, where Bioinnovo SA participates, developed IgY avian antibodies that neutralize the COVID-19 [...]
Oct
Vetanco and Bioinnovo congratulate the company Algenex on a new achievement
Algenex, the Spanish company delivering recombinant technologies, a key factor for the development of Vedevax BLOCK, [...]
Sep
Bovine Viral Diarrhea: the Argentinian vaccine will be sold in Peru
The Andean Country authorized the commercialization of Vedevax Block, the first recombinant vaccine for the control [...]
Aug
Vetanco develops an alliance with the UDESC
The constant Research and Development is a principle of Vetanco DNA and the reason why [...]
Aug
Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis
Bioinnovo, the public-private company (INTA–Vetanco) made its first contribution to the macro collaborative project conducted [...]
Jun
MIT -Massachusetts Institute of Technology – experts visited Vetanco
Following the signing of a Memorandum of Understanding/Cooperation Agreement (MOU) between the MIT startup Sunflower and Bioinnovo, Kerry Love, PhD [...]
Mar
Bioinnovo, Algenex reinforce vaccine molecule Arrangement
Argentina’s Bioinnovo has updated its partnership with Spanish firm Algenex for the use of a [...]
Dec
Bioinnovo and Algenex renew agreement for the use of APCH
Bioinnovo, the technology-based public-private company formed by the National Institute of Agricultural Technology (INTA) and [...]
Nov